Document Detail


The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity.
MedLine Citation:
PMID:  19846739     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: Insulin interacts with the GH-IGF system by a reciprocal regulation of IGF-binding proteins (IGFBP) and GH, which in turn regulate insulin sensitivity via bioactive IGF-I. This network is linked to metabolic syndrome and cardiovascular diseases. OBJECTIVE: We evaluated the effect of glucose and insulin on IGFBP-1-4, particularly IGFBP-2, in the regulation of bioactive IGF-I and its relation to insulin resistance. SETTING: The study was conducted at an endocrinology center. RESEARCH DESIGN AND METHODS: Twenty-four healthy subjects (12 men; aged 21-72 yr; body mass index 25.9 +/- 0.9 kg/m(2)) and 19 subjects with impaired glucose tolerance (IGT; eight men; aged 26-71 yr; body mass index 28.9 +/- 1.2 kg/m(2)) were prospectively studied using oral glucose tolerance test and hyperinsulinemic euglycemic clamp. RESULTS: During the clamp, insulin decreased IGF-I bioactivity in both IGT subjects and controls (-16.2 +/- 2.8 and -13.9 +/- 3.3%, respectively; P < 0.01). In addition, insulin increased IGFBP-2 and GH and decreased IGFBP-1 and -4 but did not alter total IGF-I, IGF-II, or IGFBP-3 levels. During the oral glucose tolerance test, GH and IGFBP-1 were markedly suppressed. Subjects with IGT showed more pronounced insulin resistance and lower GH, IGFBP-1, and IGFBP-2 levels (P < 0.05). In multiple regression analysis, IGFBP-2 was an independent predictor of insulin sensitivity (beta = 0.36, P < 0.05) and IGF-I bioactivity (beta = -0.5, P < 0.05). CONCLUSIONS: Our data indicate that insulin acutely decreases IGF-I bioactivity through differential modulation of IGFBPs. Furthermore, IGFBP-2 plays a central role in the insulin-IGF system cross talk and is closely linked to insulin resistance, thereby providing a further explanation for its association with the metabolic syndrome.
Authors:
Ayman M Arafat; Martin O Weickert; Jan Frystyk; Joachim Spranger; Christof Sch??fl; Matthias M??hlig; Andreas F H Pfeiffer
Related Documents :
11477509 - Effects of 36 hour fasting on gh/igf-i axis and metabolic parameters in patients with s...
18505189 - Effects of peroral insulin and glucose on circulating insulin-like growth factor-1, its...
2187189 - Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor i.
2448329 - Insulin regulates the serum levels of low molecular weight insulin-like growth factor-b...
6428119 - The hypothalamic-pituitary-thyroid axis in type 1 diabetes: influence of diabetic metab...
9142639 - Immunohistochemical evidence of insulin-like growth factor ii in human small hepatocell...
15090629 - Normal insulin sensitivity in lean offspring of obese parents.
11702969 - Effectiveness of optometrist screening for diabetic retinopathy using slit-lamp biomicr...
3836109 - Cardiorespiratory arrest in a patient with advanced diabetic autonomic neuropathy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-10-21
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  94     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-12-04     Completed Date:  2010-01-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5093-101     Citation Subset:  AIM; IM    
Affiliation:
Department of Endocrinology, Diabetes, and Nutrition, Charit??-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany. ayman.arafat@charite.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Animals
Biological Markers
Blood Glucose / metabolism
Body Mass Index
Female
Glucose Clamp Technique
Glucose Tolerance Test
Hormones / blood
Humans
Insulin / physiology*
Insulin Resistance / genetics*,  physiology*
Insulin-Like Growth Factor Binding Protein 2 / physiology*
Insulin-Like Growth Factor I / physiology*
Lipids / blood
Male
Metabolic Syndrome X / genetics,  physiopathology
Mice
Middle Aged
Obesity / genetics,  physiopathology
Young Adult
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Blood Glucose; 0/Hormones; 0/Insulin-Like Growth Factor Binding Protein 2; 0/Lipids; 11061-68-0/Insulin; 67763-96-6/Insulin-Like Growth Factor I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of Endogenous Growth Differentiation Factor 9 on Activin A-Induced Inhibin B Production in H...
Next Document:  Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.